BioMedSA’s Board of Directors approved 3 new memberships in October 2025: Cogent Consults, Nodon, and Oracle.
Jeff Jung is a medtech commercialization veteran and founder of Cogent Consults, where he seeks to help startups and growth-stage companies strategize and execute to gain market adoption. He works with clients to develop Market Development Plans that go beyond market entry—focusing on cultivating real-world usage and sustained customer engagement. His consulting practice spans five key areas: Market Assessment, Strategic Marketing, Field Marketing, Communications, and Market Access, providing a comprehensive approach to launching and scaling healthcare innovations. As BioMedSA’s first commercialization partner, Jeff is supporting the launch of BioMarketSA. He created its first program, the VACReady Bootcamp, to prepare CEOs to sell into hospitals after successfully navigating the value analysis process. Jeff’s work is grounded in a deep understanding of clinical adoption behavior and supports BioMedSA’s mission to accelerate the growth and commercial success of San Antonio’s bioscience ecosystem.
NodoN is a biotechnology startup focused on site-specific protein engineering in mammalian systems. Its proprietary genetic code expansion platform is designed to enable precise therapeutic conjugation, supporting the development of biologics with improved safety and efficacy profiles. The company collaborates with pharmaceutical partners to enhance discovery and manufacturing processes by integrating molecular design with scalable bioproduction. NodoN’s initial product is a Chinese Hamster Ovary (CHO) cell line capable of producing antibody-drug conjugates (ADCs) using click chemistry and unnatural amino acids (uAAs). This platform supports high drug-to-antibody ratios (DARs), site-selective payload attachment, compatibility with other conjugation methods, and consistent product profiles. It also aims to improve the speed and efficiency of lead molecule identification and production. The company is currently conducting drug discovery in oncology, cardiology, and neurodegeneration.
Oracle’s NetSuite, a cloud-based enterprise resource planning (ERP) platform developed, is used by a wide range of organizations to manage key business functions within a unified system. It supports operations such as financial management, supply chain and inventory control, customer relationship management (CRM), human resources, professional services automation, and ecommerce. By centralizing data and processes, NetSuite helps businesses improve operational efficiency and gain clearer insights into performance metrics. The platform is designed to be scalable, making it suitable for startups, mid-sized companies, and large enterprises across various industries.